Profile data is unavailable for this security.
About the company
Jenscare Scientific Co Ltd is a China-based company mainly engaged in the research and development of interventional products for the treatment of structural heart diseases and other related medical products. The Company develops a series of treatment solutions targeting different types of structural heart diseases. The Company's products and pipelines mainly include LuX-Valve, LuX-Valve Plus, Ken-Valve, JensClip, JensRelive, MicroFlux and SimuLock. LuX-Valve is the transcatheter tricuspid valve replacement system designed to treat patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is the transcatheter aortic valve replacement system designed to treat patients with severe aortic regurgitation or combined with aortic stenosis.
- Revenue in HKD (TTM)15.19m
- Net income in HKD-276.96m
- Incorporated2011
- Employees174.00
- LocationJenscare Scientific Co LtdBlock 5, B Area,No. 777 Binhai 4th Road, Hangzhou Bay NeNINGBO ChinaCHN
- Websitehttps://www.jenscare.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai HeartCare Medcl Tech Corp Ltd | 378.92m | 48.01m | 1.74bn | 327.00 | 37.03 | 1.41 | 21.16 | 4.59 | 1.24 | 1.24 | 9.93 | 32.47 | 0.2736 | 0.7131 | 3.54 | 1,101,506.00 | 3.47 | -13.27 | 3.66 | -13.97 | 67.49 | 66.65 | 12.67 | -90.50 | 13.16 | -- | 0.0396 | -- | 19.61 | -- | 85.51 | -- | -24.35 | -- |
| Ethk Labs Inc | 3.48bn | 197.13m | 1.86bn | 877.00 | 9.62 | 0.4796 | 7.66 | 0.5343 | 0.1205 | 0.1205 | 2.13 | 2.42 | 0.536 | 1.06 | 6.84 | 4,035,675.00 | 3.08 | 4.60 | 4.86 | 6.04 | 22.94 | 21.71 | 5.74 | 7.17 | 0.5095 | 5.12 | 0.3196 | -- | 2.40 | 6.27 | 9.35 | -1.08 | 10.78 | -- |
| Sisram Medical Ltd | 2.70bn | 160.99m | 1.89bn | 1.04k | 11.73 | 0.5178 | 5.76 | 0.6983 | 0.3437 | 0.3437 | 5.77 | 7.78 | 0.549 | 1.55 | 3.90 | 2,662,970.00 | 3.90 | 5.64 | 4.82 | 6.66 | 60.93 | 58.95 | 7.10 | 9.80 | 1.73 | -- | 0.0879 | 28.86 | -2.83 | 15.01 | -20.23 | 3.87 | 41.74 | 2.81 |
| PW Medtech Group Ltd | 955.80m | 165.81m | 1.97bn | 1.36k | 12.17 | 0.454 | 5.43 | 2.07 | 0.1101 | 0.1101 | 0.6355 | 2.95 | 0.1603 | 2.91 | 11.47 | 675,476.10 | 3.52 | 7.71 | 4.42 | 8.74 | 52.62 | 56.56 | 21.96 | 75.91 | 9.12 | -- | 0.0042 | 8.38 | 13.90 | 16.25 | -1.57 | 12.96 | 8.75 | -- |
| Guanze Medical Infrm Indstry (Hldng) Ltd | 166.94m | 23.45m | 2.84bn | 58.00 | 121.57 | 9.53 | 86.66 | 17.01 | 0.0246 | 0.0246 | 0.1764 | 0.3136 | 0.5073 | 2.21 | 1.30 | 2,928,807.00 | 7.23 | 9.50 | 8.33 | 12.04 | 36.79 | 41.43 | 14.25 | 13.09 | 5.23 | 51.53 | 0.0544 | 34.79 | -0.2127 | 2.03 | -37.59 | -5.08 | 24.24 | -- |
| OrbusNeich Medical Group Holdings Ltd | 1.32bn | 317.87m | 3.03bn | 1.43k | 9.50 | 0.9484 | 8.36 | 2.30 | 0.3854 | 0.3854 | 1.60 | 3.86 | 0.3919 | 0.9325 | 4.20 | 990,756.30 | 9.48 | 7.59 | 10.29 | 9.02 | 67.91 | 68.61 | 24.19 | 16.07 | 9.95 | -- | 0.0107 | 10.02 | 6.65 | 11.24 | -11.88 | 41.68 | 29.71 | -- |
| MicroTech Medical (Hangzhou) Co Ltd | 498.61m | -31.31m | 3.07bn | 645.00 | -- | 1.39 | -- | 6.16 | -0.0751 | -0.0751 | 1.19 | 5.29 | 0.2015 | 3.65 | 4.02 | 735,406.80 | -1.27 | -4.48 | -1.38 | -4.70 | 48.65 | 48.32 | -6.28 | -39.29 | 8.33 | -- | 0.0154 | -- | 36.48 | 46.13 | 49.51 | -- | 22.22 | -- |
| Jenscare Scientific Co Ltd | 15.19m | -276.96m | 3.29bn | 174.00 | -- | 3.34 | -- | 216.43 | -0.6794 | -0.6794 | 0.0373 | 2.36 | 0.0125 | 0.0508 | -- | 71,985.73 | -23.35 | -- | -24.76 | -- | 88.09 | -- | -1,864.69 | -- | 6.39 | -854.86 | 0.0631 | -- | -- | -- | 52.25 | -- | -- | -- |
| Peijia Medical Ltd | 755.33m | -254.75m | 4.12bn | 1.04k | -- | 1.84 | -- | 5.45 | -0.3851 | -0.3851 | 1.14 | 3.33 | 0.2561 | 1.40 | 17.04 | 721,424.50 | -8.76 | -26.57 | -10.02 | -28.99 | 69.25 | 71.23 | -34.21 | -247.65 | 1.49 | -15.30 | 0.1396 | -- | 39.53 | 101.13 | 42.28 | -- | 83.33 | -- |
| Acotec Scientific Holdings Ltd | 670.70m | 114.15m | 4.32bn | 645.00 | 36.80 | 2.64 | 24.84 | 6.44 | 0.3744 | 0.3744 | 2.23 | 5.21 | 0.3353 | 1.06 | 3.53 | 1,031,848.00 | 5.71 | 0.2467 | 6.45 | 0.289 | 75.23 | 81.33 | 17.02 | 0.7122 | 5.57 | -- | 0.1406 | 0.00 | 12.69 | 33.72 | 260.88 | 17.74 | 83.44 | -- |
Data as of Feb 16 2026. Currency figures normalised to Jenscare Scientific Co Ltd's reporting currency: Hong Kong Dollar HKD
10.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hillhouse Investment Management Ltd. (Hong Kong)as of 27 Jun 2025 | 31.73m | 10.22% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 418.80k | 0.14% |
| Polar Capital LLPas of 31 Dec 2025 | 65.00k | 0.02% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 41.40k | 0.01% |
| DFA Australia Ltd.as of 30 Nov 2025 | 534.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
